Gene · 994
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction to "IER5 Negatively Regulates Cdc25B Expression in HeLa Cells After Gamma Ray Irradiation". | Biomed Res Int | 2026 | 42608995 | PubTator, text mining | PubMed |
| Identification and Validation of an E2F Targets-Related Gene Signature Risk Score Predicting the Prognosis of Patients with Uveal Melanoma. | Ocul Oncol Pathol | 2026 | 42553888 | PubTator, text mining | PubMed |
| Novel CDK-independent function of CDC25 phosphatases in mRNA translation. | EMBO Rep | 2026 | 42448957 | PubTator, text mining | PubMed |
| Differential DNA Methylation and Delirium After Anesthesia and Surgery. | medRxiv | 2026 | 42369472 | PubTator, text mining | PubMed |
| Exploring a critical time window for FOXM1-driven bladder injury in chronic arsenic exposure. | Ecotoxicol Environ Saf | 2026 | 42190387 | PubTator, text mining | PubMed |
| Chemical components from Uncaria gambir (W.Hunter) Roxb. and their preliminary bioactivities in CDC25B phosphatase inhibition and vasodilatory activity. | Nat Prod Res | 2026 | 42176307 | PubTator, text mining | PubMed |
| The Binding of 3-O-Methylfluorescein Phosphate to the Catalytic Domain of the Human CDC25B Phosphatase: A Structural Investigation. | Chembiochem | 2026 | 41906666 | PubTator, text mining | PubMed |
| AI-derived prognostic model identifies high-risk gene signatures in pediatric gliomas. | Front Immunol | 2026 | 41878416 | PubTator, text mining | PubMed |
| A hybrid molecular-imaging model for high-accuracy early colorectal cancer diagnosis. | J Gastrointest Oncol | 2026 | 41816600 | PubTator, text mining | PubMed |
| Paired-Box (PAX) Gene Signatures as a Biomarker of Breast Cancer Progression. | Int J Mol Sci | 2026 | 41752124 | PubTator, text mining | PubMed |
| FOXM1 induces therapy resistance and inhibits apoptosis in a variety of human cancers. | Cell Death Dis | 2026 | 41714589 | PubTator, text mining | PubMed |
| Mechanistic evidence for dibutyl phthalate as an environmental trigger for inflammatory bowel disease. | iScience | 2026 | 41630903 | PubTator, text mining | PubMed |
| Discovery of the MELK-Nucleostemin Axis in Glioblastoma: Implications for p53 Regulation and Tumor Progression. | J Microbiol Biotechnol | 2026 | 41605804 | PubTator, text mining | PubMed |
Farrerol inhibits proliferation and migration of colorectal cancer via the VEGF signaling pathway: evidence from network pharmacology, molecular docking, molecular dynamics simulation, and in vitro experiments. | Front Pharmacol | 2025 | 41415563 | PubTator, text mining | PubMed |
| Systematic druggable genome-wide mendelian randomization identifies therapeutic targets for childhood asthma. | Medicine (Baltimore) | 2025 | 41398767 | PubTator, text mining | PubMed |
| Circulating tumor cells as prognostic biomarkers in advanced gastric cancer treated with CDC25B phosphatase inhibitors. | Sci Rep | 2025 | 41315323 | PubTator, text mining | PubMed |
| Integrative eQTL and Mendelian randomization analysis reveals key genes in colorectal cancer. | Discov Oncol | 2025 | 41252059 | PubTator, text mining | PubMed |
| Bioinformatics-based screening and validation of ferroptosis-related genes in sepsis and type 2 diabetes mellitus. | Exp Biol Med (Maywood) | 2025 | 41194984 | PubTator, text mining | PubMed |
| The methyltransferase-like proteins as core regulators of nucleic acid modifications and post-translation modification of proteins in disease pathogenesis and therapeutic implications. | Biomark Res | 2025 | 41194259 | PubTator, text mining | PubMed |
| Deciphering splicing heterogeneity at single-cell resolution by SCSES. | Nat Commun | 2025 | 41145486 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/994/papers